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Summary
Background: In the last 2 decades there has been a large 
increase in publications on complementary and alterna-
tive medicine (CAM). However, CAM research methodol-
ogy was heterogeneous and often of low quality. The 
aim of this systematic review was to investigate scien-
tific publications with regards to general issues, con-
cepts and strategies. We also looked at research priori-
ties and methods employed to evaluate the clinical and 
epidemiological research of CAM in the past to identify 
the basis for consensus-based research strategies. Meth-
ods: We performed a systematic literature search for 
 papers published between 1990 and 2010 in 7 electronic 
databases (Medline, Web of Science, PsychArticles, Psy-
cInfo, CINAHL, EMBASE and Cochrane Library) on De-
cember 16 and 17, 2010. In addition, experts were asked 
to nominate relevant papers. Inclusion criteria were pub-
lications dealing with research methodology, priorities 
or complexities in the scientific evaluation of CAM. All 
references were assessed in a multistage process to 
identify relevant papers. Results: From the 3,279 refer-
ences derived from the search and 98 references contri-
buted by CAM experts, 170 papers fulfilled the criteria 
and were included in the analysis. The following key is-
sues were identified: difficulties in past CAM research 
(e.g., randomisation, blinding), utility of quantitative and 
qualitative research methods in CAM, priority setting in 
CAM research and specific issues regarding various 
CAM modalities. Conclusions: Most authors vote for 
the use of commonly accepted research methods to 
evaluate CAM. There was broad consensus that a mixed 
methods approach is the most suitable for gathering 
conclusive knowledge about CAM.
Introduction
CAMbrella is a European Union (EU)-funded coordinated 
action in the field of complementary and alternative medicine 
(CAM). To address the increasing use of CAM and the lack 
of scientific knowledge concerning CAM use, the CAMbrella 
Work Package 7 (WP7) group is developing a ‘roadmap for 
further clinical and epidemiological research in CAM’. Here 
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of the following additional exclusion criteria was fulfilled: (i) it mainly 
 addressed research methodology of basic and experimental research; (ii) 
it primarily addressed the reporting of clinical trials; (iii) it primarily as-
sessed methodological quality/rigour of CAM-evaluation trials; (iv) it 
presented a case study or abstract only; or (v) it mainly reported a specific 
study design or research tool.
Full-text analysis and inclusion/exclusion based on the full text was 
conducted primarily by 1 reviewer (Felix Fischer). To check the rigour of 
the exclusion process, excluded articles underwent a second review and 
inclusion/exclusion was discussed by 3 reviewers (Felix Fischer, Benno 
Brinkhaus, Claudia Witt) until consensus was found. All arguments 
 appearing within the included references were categorised and relevant 
information was extracted. Categories emerging from the original publi-
cations were continuously reordered and discussed within the WP7 group.
Results
The literature search resulted in 3,279 hits and CAMbrella 
members contributed 98 additional references. After the ex-
clusion process, 170 studies were included in the qualitative 
synthesis. See figure 1 for additional information.
we report the results of a systematic literature review on gen-
eral issues in CAM research as a first step towards the devel-
opment of a research roadmap. Research in CAM has been a 
controversial topic (for a broad overview on CAM research 
see [1]), and our aim was to create a comprehensive evalua-
tion and analysis of the methodological and conceptual issues 
involved.
We therefore performed a systematic review of literature 
dealing with the complexities and general methodological is-
sues involved in the evaluation of CAM in clinical and epide-
miological research. Ultimately, the outcome of this review, 
the subsequent discussion and the final roadmap for further 
research, should lead to a basis and framework for further 
CAM research in Europe.
Methods
A structured systematic literature review was conducted. Before starting 
this review, a systematic review protocol was developed (initial draft by 
the WP7 leader), which was submitted to the whole WP7 group for notes 
and suggestions for changes. The final version of the review protocol (in-
cluding the search terms) was approved by the whole WP7 group.
Literature Search
In 2010, 7 electronic databases (Medline, Web of Science, PsychArticles, 
PsycInfo, CINAHL, EMBASE and Cochrane Library) were searched for 
relevant articles published between 1990 and 2010 (until December 16/17). 
Table 1 shows the search terms entered into the databases. In addition to 
the database search, all experts and the advisory board involved in the 
CAMbrella project were asked to submit any relevant publications.
Selection
Duplicates were excluded. We mainly aimed for full articles and original 
works, but comments, editorials, letters and ‘grey’ literature were in-
cluded when a substantial original contribution to the topic was found. 
The title and abstract of the remaining references were screened by 1 re-
searcher (Florian Junne) to exclude irrelevant references that were not 
related to CAM at all, not in a European language, on basic research only 
or on animal studies. Secondly, the title and abstract of the remaining 
 articles were evaluated by 2 reviewers (Florian Junne and Felix Fischer) 
to identify publications that included investigations, analysis, discussion, 
proposals or statements concerning the following: i) qualitative and quan-
titative methods, ii) clinical and epidemiological research methodology, 
iii) priorities or priority setting or iv) methodological complexities in-
volved in the scientific evaluation of CAM.
Articles with a corresponding judgment from both reviewers were in-
cluded in further analysis. Kappa as measure of inter-rater agreement was 
calculated. For non-corresponding judgments, the 2 reviewers discussed 
the title and abstract of the publication until an agreement regarding in-
clusion or exclusion was achieved. Publications contributed by CAM ex-
perts (additional references were contributed by the authors of the review 
and the CAMbrella Advisory Board members Nora Laubstein, Ton Nico-
lai, Peter Zimmermann and Stephen Gordon) were also reviewed and in-
cluded in full-text analysis if they met the inclusion criteria after rating of 
title and abstract.
Full-Text Analysis and Data Extraction
All included publications entered full-text analysis. The eligibility of the 
publications was re-examined with respect to the above-mentioned inclu-
sion/exclusion criteria. At this stage, publications were also excluded if 1 
Table 1. Search terms for electronic databases
AND
Complementary therapies$ research 
OR
Complementary medicine method*
Complementary therap* methodological research
Alternative medicine* research design
Alternative therap* study design
Integrative medicine* whole system research
Integrative therap* complexity research
Unconventional medicine* complex interventions research
Unconventional therap* qualitative research
Traditional medicine research priorities
Supplement* research strategy
Herbal  
Homeopathy  
Osteopathy  
Acupuncture  
Traditional Chinese medicine  
Mind-body therap*  
Naturopathy  
Meditation  
Massage  
Ayurveda  
Chiropractic medicine  
Manipulation  
Biofield therap*  
Reiki  
Therapeutic touch  
Yoga  
Aromatherapy  
Prayer  
Anthroposophic medicine  
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possible in the field of CAM and can therefore produce valid 
data [4, 11, 17, 30–48], but they must be rigorously performed 
and CAM-specific challenges must be addressed, such as the 
lack of external validity due to strict standardisation of di-
verse treatments and study participants [3, 30, 32, 37, 38, 41–
43, 48–59]. However, a consensus emerged that clearly im-
plied that RCTs do not answer all research questions [28, 36, 
52, 60–64] and are expensive to conduct [18, 30, 32, 52, 65, 66]. 
Some authors argue that placebo-controlled RCTs might be 
inappropriate for some specific CAM modalities [67–69]: a 
position that has raised considerable controversy [47, 70]. In-
tegration of diverse research methods [2, 12, 27, 38, 61, 71], 
preference trials [3, 72, 73] or the use of different outcome 
measures [74, 75] could help overcome these shortcomings. 
Feasibility studies are a vital preliminary phase in the design 
of high-quality RCTs with adequate power [3, 4, 10, 76–79]. 
When individualised and standardised treatments are to be 
compared [3], or if specific and non-specific effects need to be 
separated [80], RCTs can be extended to more than 2 treat-
ment arms to account for preference towards a specific treat-
ment in preference trials [20, 28, 72, 73].
Pragmatic trials – as promoted in Comparative Effective-
ness Research (CER) – can be conducted to assess outcomes 
Practical Problems in Research into CAM
We found a large number of publications dealing with practi-
cal problems when conducting research in CAM. These prob-
lems and relevant references are categorised in detail in 
table 2.
Choice of Research Methods
The choice of research method depends on the question asked 
[2–6]. In some publications, explicit research questions and 
appropriate methods were given by the authors [2, 5, 7–11]. 
However, there was clear agreement about the value of differ-
ent research methods in CAM research [12–16]. Most authors 
suggested a research-question-driven integration of diverse 
methods into the research agenda [6–8, 13, 16–29].
Quantitative Research Methods
Randomised controlled trials (RCTs) are considered to be the 
gold standard to assess specific effects and efficacy and to de-
termine causal relationships in biomedical research. Most au-
thors stated that RCTs with high methodological quality are 
Fig. 1. Flowchart of literature review process.
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of the topic under study [67], to gather basic knowledge about 
CAM treatments [89] or to identify relevant, but uncommon 
outcomes [89, 105]. However, rigour and sophistication of 
case reports could be improved [10, 67, 106].
There was a strong consensus that both qualitative and 
quantitative methods are valuable and should be combined in 
the CAM research agenda, e.g., qualitative methods to formu-
late hypothesis on mechanisms (which might be tested by quan-
titative methods) as well as in specific clinical studies, e.g., to 
assess reasons for dropouts, identification of the most relevant 
outcomes or to generally improve interventions [2, 14, 16, 18, 
22, 25, 26, 28, 42, 71, 98, 100, 102, 107–110]. The use of qualita-
tive methods has been particularly discussed as a preliminary 
basis for preparation of clinical trials [25, 28, 29, 79, 97, 101].
Applying Research Methods Used in Conventional Medicine  
to CAM
Research methods used in conventional medicine can and 
should be used for research in CAM as well [7, 15, 17, 44, 55, 
73, 81, 87, 111–114]. Most authors agreed that the methodo-
logical standards of medical research can be applied to CAM 
research [4, 11, 13, 17, 29, 32, 35, 40, 46, 47, 70, 115, 116], but it 
might be necessary to adapt the research designs in some 
areas [6, 12, 15, 43, 57, 58, 62, 69, 87, 88, 117, 118] to account 
for the complexity of CAM interventions [15, 17, 87, 119, 120]. 
This is the case not only for CAM, but also for complex and 
individualised treatments in conventional medicine [72]. 
However, some authors felt that the underlying assumptions 
between conventional medicine and CAM differ so funda-
mentally [8, 18, 39, 64, 121, 122] that specific research meth-
ods for CAM are necessary.
Research Priorities
No definite statement can be made concerning the question of 
which kind of research should be prioritised in CAM, but it 
was argued that the specification of research priorities is im-
portant, as the methods of assessment must be derived from 
the research question and not vice versa [13]. Various criteria 
were proposed for deciding on the priorities of future CAM 
research in general, such as prevalence of use and burden of 
disease [7, 8, 29, 45, 46, 81, 82, 92, 107, 123–126], and also for 
specific fields and modalities of CAM [76, 78, 114, 123, 127, 
128], where priorities might differ [129]. The context, founda-
tions and philosophical background of CAM treatments [13, 
26, 28, 57, 58, 71, 76, 97, 99, 119, 121, 130–132] are an impor-
tant basis through which to understand the differences be-
tween CAM practices and conventional medicine. The safety 
of different CAM treatments needs to be assessed [46, 57, 58, 
64, 82, 89, 91, 119, 133] to protect patients using CAM [46], 
even though CAM is generally considered safe [55, 81].
There were 2 contradicting views regarding effectiveness 
versus efficacy studies. Although there seems to be no disa-
of a treatment within a real world clinical setting (clinical ef-
fectiveness) [36, 69, 81–83]. Pragmatic trials enable compari-
son of clinical treatment alternatives, inclusion of a wide vari-
ety of patients in diverse practice settings and address a 
broad range of patient relevant outcomes [2, 83]. Over the 
years, the general nature of research questions in CAM has 
shifted from efficacy to effectiveness [2, 36, 81]. Pragmatic 
trials involve randomisation [20, 33, 83, 84] and treatment has 
to be defined adequately and clearly [53, 83, 85]. In contrast 
to the wide use of explanatory RCTs addressing efficacy, 
pragmatic trials have greater external validity [19, 20, 38, 44, 
52, 83, 85, 86]. They also allow the evaluation of complex in-
terventions triggering a variety of specific and non-specific 
effects [29, 36, 87, 88], can include cost evaluations [52, 84], 
but cannot identify specific mechanisms of action within a 
treatment [18, 20, 82, 83].
Observational studies might be a feasible method for eval-
uation of CAM and sometimes lead to results that are compa-
rable with RCTs [15, 17, 20, 44, 52, 59]. This approach could 
represent a potential alternative if RCTs are seen to be inap-
propriate, too expensive or too complicated [13, 20, 67, 69, 
89], if general effectiveness of an intervention is the focus of 
interest [24, 52] or to assess CAM use in the population [45]. 
Results of observational studies can influence the design of 
further interventional trials [17, 42]. Uncontrolled observa-
tional studies, however, give little information about effects of 
treatment [47], and their weak internal validity must be ad-
dressed [20]. A particular method that has been discussed is 
the Best Case Series [29, 90–92].
The use of quantitative methods, such as factorial and ex-
perimental designs [20, 24, 63, 72, 93], has also been proposed. 
N-of-1 trials (repeated intervention of 1 approach in 1 person) 
were discussed extensively as a methodology to achieve valid 
results on the level of the individual patient. It could be ap-
propriate when studying customised treatment of many CAM 
modalities [20, 49, 72, 74, 94, 95]. However, these trials are 
uncommon in published research and need to be planned and 
executed carefully [96].
Qualitative Research Methods
In relation to studies of outcomes of specific therapies, quali-
tative research may be used to assess the subjective views of 
individuals [14, 8, 25, 26, 44, 97, 98]. This can help to establish 
a patient-centred mechanistic understanding of the interven-
tion and its impact, irrespective of whether mechanisms and 
objective outcomes of treatments are known [16, 26, 56, 97–
100]. Qualitative research is unsuitable when trying to estab-
lish causal relationships or specific physiological outcomes 
[101], but is relevant for the investigation of changes in sub-
jective approaches to health and illness [5]. Specific qualita-
tive research methods have been introduced in the literature, 
such as ethnographic research, interviews and focus groups [5, 
16, 98, 102–104]. Case reporting and case studies are particu-
larly valuable to establish complex and contextualised views 
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The Role of Different Modalities in CAM Research
Issues concerning a broad range of different CAM modalities 
in CAM research have been discussed in the literature, with 
acupuncture (as part of Chinese medicine) and homeopathy 
being the specific CAM modalities addressed most frequently. 
Use and design of RCTs in acupuncture research have been 
discussed extensively [3, 15, 32, 40, 43, 48, 50, 55, 151–153]. A 
major issue is the choice of appropriate control groups (in-
cluding the design of credible placebo and sham treatments) 
and blinding [32, 33, 102, 143–145, 152, 154, 155]. Specific 
 acupuncture-related suggestions for further research have 
also been given [57, 58, 85, 108, 127, 145]. Similarly, specific 
 issues involving in the design of homeopathic studies have 
been discussed in detail [75, 112, 113, 156, 157], e.g., the sepa-
ration of non-specific and specific effects [68, 80] and the han-
dling of patient preferences within a randomisation procedure 
[88]. The shift from efficacy to effectiveness studies in home-
opathy [78, 84] has been suggested to be of more clinical value.
A specific argument that has been raised regarding dietary 
supplements and herbal medicine is their varying quality and/
or composition since there is no adequate standardisation of 
production for these medicines [30, 55, 158, 159]. Developing 
an appropriate placebo is crucial especially when there is a 
difference of taste between the active drug and suggested pla-
cebo [49, 99, 158]. There were fewer modality-specific publi-
cations for Ayurveda [21], bodywork (such as Feldenkrais) 
[37], chiropractic [18, 25, 76, 89], classic Arabic medicine 
[103], diet [73, 120], healing [22, 23, 53, 56, 107, 131], hypnosis 
[86, 136], traditional Japanese medicine [123], massage [93], 
meditation [2, 100], Oriental medicine [6], (intercessory) 
prayer [24, 42, 160], Qigong [51], reflexology [9], Tai Chi [62] 
and Yoga [115]. 
Discussion
This literature review summarises and reflects the on-going 
discussion within the scientific community regarding CAM re-
search over the last 20 years. To the best of our knowledge, 
this is the first systematic review, following a clearly defined 
protocol, aimed at assessing the current situation of clinical 
and epidemiological research methodology in CAM. How-
ever, developing definitions of inclusion and exclusion criteria 
has been proved difficult. Also, although 2 reviewers con-
ducted reference selection and 3 reviewers checked the full 
texts, first screening was only done by 1 reviewer.
In light of the current literature on CAM research method-
ology there is broad consensus that the commonly accepted 
research methods that are used in conventional medicine can 
and should be applied to evaluate CAM. This applies espe-
cially to RCTs. However, the literature reflects a movement 
from double-blind, placebo-controlled, randomised trials (to 
explain specific mechanisms and efficacy, as conducted in 
greement that both types of research have their own place, 
validity and importance [13, 33, 36, 66, 82, 88], some authors 
argue [11, 36, 48, 57, 58] that efficacy research should be pri-
oritised over effectiveness research to legitimise the use of 
CAM and to help to increase acceptance [55, 108, 134]. Other 
authors state that efficacy research to examine specific effects 
should not be undertaken until overall effectiveness of the 
therapy in question is demonstrated to prevent misuse of 
scarce resources [76, 81, 119, 135]. This discussion also reflects 
different opinions on the importance and value of specific and 
non-specific effects within the whole of clinical practice [18, 
19, 36, 53, 66, 78, 81, 82, 85, 86, 136–140].
An integrative research approach has been described as si-
multaneous research into mechanisms and overall effective-
ness of CAM treatments [13, 31, 88]. The health economic 
evaluation of CAM treatments was seen as particularly rele-
vant in modern healthcare [141, 142]. Research into the mech-
anisms of placebo, context or meaning effects were also seen 
as important to determine appropriate control groups and 
their respective explanatory power [143–145], to explain po-
tentially contradictory study results [144] and to maximise 
these effects in clinical practice [46, 144].
Research Strategies and General Frameworks on Research  
in CAM
Some authors have developed general frameworks for CAM. 
A number of frameworks are applicable; many have overlap-
ping concepts and may be described as ‘whole systems re-
search’ [20, 89, 99, 130], ‘outcome research’ [44, 52, 66, 105, 
146–148] or ‘health services research’ [76]. These approaches 
focus on the investigation of processes and outcomes in a sys-
temic manner [130] in routine clinical practice [76]. They pri-
marily reflect the concepts of effectiveness research and are 
designed to take the complexity of CAM into account [20, 87] 
while ensuring maximal external validity and clinical rele-
vance [130, 149].
An approach that has received considerable attention is 
the ‘reversed research strategy’ for CAM, in contrast to drug 
research [57, 58, 76, 81, 119], where initial observational re-
search in the context of areas, such as usage and safety, is fol-
lowed by research into the overall effectiveness and then by 
efficacy research.
Concepts, such as the ‘evidence house’ [13], the ‘circular 
research model’ [12] or the ‘rational sequences of research 
 designs’ [81] put emphasis on a broad perspective of research 
designs to gather evidence on the effects of CAM. A general 
framework to explore ‘healing relationships’ is suggested [23], 
again with emphasis on methodological pluralism. Cognition-
based medicine (CBM) [150] is suggested as an alternative 
or additional framework for studying the perceived causality 
of treatment effects.
Forsch Komplementmed 2012;19:51–60Key Issues in CAM Research – Systematic  
Review
57
Most authors are in favour of a broad integration of differ-
ent research methods to gather evidence about the clinical ef-
fects of CAM. There is a strong consensus that both qualita-
tive and quantitative methods are valuable and should be com-
bined within the CAM research agenda using a mixed methods 
approach. This would involve qualitative methodology, for ex-
ample, to understand the feasibility of running a study, devel-
oping the appropriate outcomes and formulating hypotheses 
about the psychological mechanisms involved in the complex 
intervention. This information would then be evaluated utilis-
ing quantitative methods in specific clinical studies.
The above-mentioned aspects in clinical and epidemiologi-
cal CAM research were discussed at a CAMbrella workshop 
with distinguished experts in the field of CAM research to de-
velop recommendations for further research into CAM. The 
invited experts were Wayne Jonas, Klaus Linde, Hugh 
MacPherson, Charlotte Paterson, Harald Walach and Claudia 
Witt and as members of CAMbrella’s Advisory Board Sea-
mus Connolly and Peter Zimmermann. These recommenda-
tions form the basis of the CAMbrella ‘roadmap for future 
clinical and epidemiological research in CAM’.
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drug-research) towards more pragmatic trials that compare 
meaningful clinical alternatives in heterogeneous groups of 
patients. Efficacy research was hampered by a lack of consen-
sus-based and testable underlying theories for many CAM 
modalities, e.g., when designing appropriate placebo or sham 
treatment. The assumptions underlying the rationale of dou-
ble-blind placebo-controlled RCTs were also difficult to fulfil 
for most CAM modalities, e.g., patient and treatment-pro-
vider blinding. Consequently, the results of efficacy research 
have often been inconclusive and difficult to interpret. On the 
other hand, research into the overall clinical effects of CAM 
promises more relevant results for clinical decision-making, 
and within the framework of comparative effectiveness re-
search RCTs of high methodological quality are possible. 
These challenges and the current trend towards the evalua-
tion of treatments in clinical contexts are not restricted to 
CAM but affect all areas of complex interventions in medi-
cine [161–163].
Giving priority to comparative effectiveness research does 
not devalue the importance of basic research on mechanisms 
of action in CAM, which is needed to facilitate interpretation 
of efficacy and effectiveness research. A previous independent 
advisory group [164] stated that trials into effectiveness and 
cost-effectiveness are primarily needed, but the mechanisms of 
action of CAM also need to be assessed. In addition, further 
basic research is needed on the mechanisms of action of pla-
cebo intervention or sham controls.
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